Lier: Net profitis expected to be 260 million to ¥280 million in the first quarter of 2023
Lier Chemical on April 3 released the first quarter of 2023 performance forecast, the netprofit attributable to shareholders of listed companies is expected to be 260million yuan to 280 million yuan, a year-on-year decline of 51.34% to 47.60%. Net profit attributable to shareholders of listed companies after deducting non-recurring gains and losseswas 260 million yuan to 280 million yuan, down 50.77% to 46.99% year-on-year.
The announcement showed that during thereporting period, the company's core product ammonium industry competition intensified, resulting in Glufosinate ammoniumsales price decreased significantly year-on-year, affecting the company's operating performance in the first quarter year-on-year decline.
2026-08-13
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
BASF's Agrochemicals Division Is Preparing to Raise Funds for Listing in the United States or Germany
-
Basf plans to close two of its Glufosinate ammonium production sites in Germany to deal with the global serious overcapacity!
-
India has decided to impose anti-dumping duties on Sodium cyanide and initiate an anti-dumping investigation on Glufosinate ammonium
-
Agri Tech(India) will be held in Bangalore from August 22-24
-
Invest 45 million! Lier (Hunan) plans to build 100,000 tons of green plant protection formulation project (Glufosinate-P)
-
Invest 45 million! Lier (Hunan) plans to build 100,000 tons of green plant protection formulation project (Glufosinate-P)
-
The Brazilian market for biological inputs for the 2022-2023 planting season grew by 52%
-
China:The price of Glufosinate ammonium TK hit a new low in ten years
-
Limin to expand 6 products production capacity
-
Thiamethoxam is again approved for sale, use, production and import in Brazil
Recommend Reading
-
Lotte Merges with HD Hyundai: Can Korea’s Petrochemical First Case Trigger True Restructuring?
-
Pregabalin vs Gabapentin: Differences, Uses, and Side Effects
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
-
From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse
-
BASF Raises API and Excipient Prices
-
In November, Shandong Local Refineries' Gasoline and Diesel Prices Show Divergence
-
Crude Oil and Supply-Demand Dynamics Drive Toluene Market to First Decline and Then Rise in April
-
In April, the overall trend of maleic anhydride in China declined
-
April DMF Market Prices Show an Initial Rise Followed by a Decline
-
Improved Supply-Demand Dynamics Drive PTA Prices to Fluctuate and Rise in November